1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [f6c3a361-de3a-4f7e-88e5-263084dcf3af] => Array
        (
            [runtime-id] => f6c3a361-de3a-4f7e-88e5-263084dcf3af
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [9c9332e5-9ba6-422a-b803-48229673a63d] => Array
                        (
                            [runtime-id] => 9c9332e5-9ba6-422a-b803-48229673a63d
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;6c9084d1c4b58da5e73e962a4daf05d4c9bf03cb
                )

        )

)
1naresh2naresh<pre>Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

    [2dd52a9a-1802-42f3-9b64-605dd4effea1] => Array
        (
            [runtime-id] => 2dd52a9a-1802-42f3-9b64-605dd4effea1
            [type] => toll-free-key
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [da0c666a-6126-4a82-95df-5b7867e0a567] => Array
                        (
                            [runtime-id] => da0c666a-6126-4a82-95df-5b7867e0a567
                            [type] => toll-free-key
                        )

                )

            [credentials] => Array
                (
                    [method] => toll-free-key
                    [value] => tf_ipsecsha;6c9084d1c4b58da5e73e962a4daf05d4c9bf03cb
                )

        )

)
RT Journal Article
SR Electronic
T1 Carotid Artery Stenting: Technical Considerations
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 1736
OP 1743
VO 21
IS 9
A1 Vitek, Jiri J.
A1 Roubin, Gary S.
A1 Al-Mubarek, Nadim
A1 New, Gishel
A1 Iyer, Sriram S.
YR 2000
UL http://www.ajnr.org/content/21/9/1736.abstract
AB BACKGROUND AND PURPOSE: Carotid endarterectomy (CEA) is one of the most frequently performed operations in the United States. To offer patients a less invasive means to achieve the same goal, carotid artery stenting (CAS) is investigated as an alternative treatment to CEA.METHODS: Three hundred ninety patients underwent CAS, with 451 vessels treated. CAS was performed using a coaxial system with a 7F 90-cm sheath for predilation, stent placement, and stent dilation. Pretreatment antiplatelet therapy was administered. We currently practice same-day admissions and 23-hour discharges.RESULTS: The technical success rate was 98%. The 30-day mortality/morbidity rates were as follows: death, 1.7% (two [0.5%] neurologic and five [1.2%] systemic] major strokes, 0.9% (two of four were related to the intervention); minor strokes, 5.5%. Among 25 patients who suffered minor strokes, 14 achieved complete recovery. On an annual basis, the incidence of minor stroke declined from 6.8% (1994–1995), to 5.8% (1995–1996), 5.3% (1996–1997), and then 4% (1997–1998), with no major strokes or neurologic deaths occurring during the 1997 to 1998 period.CONCLUSION: CAS is an effective treatment for carotid stenosis. With proper selection of patients and meticulous technique, complication rates compare favorably with those of CEA.